Xing Ji

机构：Capital Medical University, Peking University, Nanjing Children's Hospital, Gansu University of Traditional Chinese Medicine, Beijing Chest Hospital, Gansu Provincial Hospital, Micropore Technologies (United Kingdom), Peking University First Hospital, Second Affiliated Hospital of Nanjing Medical University, Wuhan Third Hospital, Beijing Shijitan Hospital, Micron (Singapore) · ORCID：0000-0003-2640-5914

发表论文 73 篇 · 总被引 991 次 · h-index 20

代表论文

• The Mechanism, Clinical Efficacy, Safety, and Dosage Regimen of Atomoxetine for ADHD Therapy in Children: A Narrative Review (2022 · Frontiers in Psychiatry · 被引 64)
• BMAL1 inhibits renal fibrosis and renal interstitial inflammation by targeting the ERK1/2/ELK-1/Egr-1 axis (2023 · International Immunopharmacology · 被引 22)
• Columbianetin alleviates lipopolysaccharides (LPS)-induced inflammation and apoptosis in chondrocyte through activation of autophagy by inhibiting serum and glucocorticoid-induced protein kinase 1 (SGK1) expression (2022 · Bioengineered · 被引 22)
• Identification of biomarkers for knee osteoarthritis through clinical data and machine learning models (2025 · Scientific Reports · 被引 16)
• Smurf1 polyubiquitinates on K285/K282 of the kinases Mst1/2 to attenuate their tumor-suppressor functions (2023 · Journal of Biological Chemistry · 被引 10)
• Phosphorylation of human glioma-associated oncogene 1 on Ser937 regulates Sonic Hedgehog signaling in medulloblastoma (2024 · Nature Communications · 被引 9)